Mayo Clinic, GE HealthCare launch strategic collaboration seeking to innovate in imaging and theranostics

The Mayo Clinic and GE HealthCare have launched a new strategic collaboration as the two seek to develop new innovations in medical imaging and theranostics.

Both will work in tandem to produce new research and products, aspiring to “transform the experience of patients and clinicians in the practice of radiology.”

“We are at a critical time in healthcare—technology is rapidly evolving, and we have a responsibility to drive healthcare capabilities through clinical translation and adoption of advanced technologies,” Matthew Callstrom, MD, PhD, chair of radiology at the Rochester, Minnesota-based Mayo Clinic, said in a Sept. 14 announcement from GE. “This collaboration brings our research and clinical teams’ expertise and feedback closer to product development and commercialization of innovation, ultimately accelerating the rate of translation of our research to patient care and offering greater opportunity for global impact.”

The two organizations said their work will focus on four core areas: (1) advancing MRI techniques and technologies, (2) transforming care through the development of targeted theranostic agents, (3) making ultrasound easier and faster to use, and (4) leveraging data, AI and digital health tools to improve the patient experience.

Collaboration activities and research will take place at Mayo’s Minnesota campus. GE and the noted health system said they also plan to work with other specialties impacted by radiology including cardiology, oncology, radiation oncology, vascular medicine, neurology, nuclear medicine and urology.

Marty Stempniak

Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic. 

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Trimed Popup
Trimed Popup